Showing results (1881-1890 of 3,006) with videos related to

Sort By:
Pageof 301
European Journal of Medicinal Chemistry|December 3, 2019
Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitorReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Heart (British Cardiac Society)|January 26, 2020
Characteristics and outcomes of patients with normal left atrial pressure undergoing transcatheter mitral valve repairJason R Sims, Guy S Reeder, Mayra Guerrero, et al.
The Annals of Thoracic Surgery|October 1, 1993
Esophagectomy in the septuagenarianK S Naunheim, J Hanosh, J Zwischenberger, et al.
Frontiers in Oncology|July 15, 2021
A Novel HAGE/WT1-ImmunoBody® Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine AloneRukaia Almshayakhchi, Divya Nagarajan, Jayakumar Vadakekolathu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2022
The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology ExampleEmilie D Duchesneau, Bradford E Jackson, Michael Webster-Clark, et al.
Cancer Research|June 21, 2020
ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase InhibitorsRavyn M Duncan, Leticia Reyes, Katelyn Moats, et al.
European Journal of Biochemistry|November 25, 1997
Platination of a GG site on single-stranded and double-stranded forms of a 14-base oligonucleotide with diaqua cisplatin followed by NMR and HPLC -- influence of the platinum ligands and base sequence on 5'-G versus 3'-G platination selectivityF Reeder, Z Guo, P D Murdoch, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2012
Strategy for directing combinatorial genome engineering in Escherichia coliNicholas R Sandoval, Jaoon Y H Kim, Tirzah Y Glebes, et al.
Blood Cancer Journal|November 18, 2025
A superantigen-based MHC class II-targeted cancer immunotherapy for the treatment of acute myeloid leukemiaLena Golick, Reeder M Robinson, Leticia Reyes, et al.
Leukemia Research|June 25, 2017
Multicenter phase 2 study of combination therapy with ruxolitinib and danazol in patients with myelofibrosisK Gowin, H Kosiorek, A Dueck, et al.
Pageof 301